Please protect the confidentiality of your patients by not revealing or sharing login credentials.
Register Now

To register for online services, click here:

Register Now

If you are a registered user, please login above.



Prescribing Information


CONTACT US

1-877-664-3742 1-877-664-3742
   
Fax Number 1-855-664-3741

Monday through Friday
9:00 am to 6:00 pm ET
P.O.Box 220609,
Charlotte NC 28222-0609

Support Services

Welcome to Omeros Provider Portal Learn More

IMPORTANT SAFETY INFORMATION

OMIDRIA must be added to irrigation solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.

Systemic exposure of phenylephrine may cause elevations in blood pressure.

Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.

The most commonly reported adverse reactions at 2-24% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Use of OMIDRIA in children has not been established.

Please see the Full Prescribing Information for OMIDRIA at www.omidria.com/prescribinginformation.

You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS AND USAGE

OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

*To be eligible for the OMIDRIAssure program services, patients must be enrolled in the OMIDRIAssure program. To be eligible for the "Equal Access" Patient Assistance Program patients must be enrolled prior to surgery. Program is subject to change without notice. Benefit verifications may not address contracted payer payment rates. For any patient eligible for the "Equal Access" Patient Assistance Program, (1) the facility receives a free vial of OMIDRIA prior to surgery and (2) the patient's insurance carrier(s) should not be billed for OMIDRIA.